FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2952337170> ?p ?o ?g. }

• W2952337170 abstract "Background: MicroRNAs have been implicated in the pathogenesis of rheumatoid arthritis (RA), obesity, and altered metabolism. Although RA is associated with both obesity and altered metabolism, expression of RA-related microRNA in the setting of these cardiometabolic comorbidities is unclear. Our objective was to determine relationships between six RA-related microRNAs and RA disease activity, inflammation, body composition and metabolic function. Methods: Expression of plasma miR-21, miR-23b, miR-27a, miR-143, miR-146a, and miR-223 was measured in 48 persons with seropositive and/or erosive RA (mean DAS-28-ESR 3.0, SD 1.4) and 23 age-, sex- and BMI-matched healthy controls. Disease activity in RA was assessed by DAS-28-ESR. Plasma cytokine concentrations were determined by ELISA. Body composition was assessed using CT scan to determine central and muscle adipose and thigh muscle tissue size and tissue density. Plasma and skeletal muscle acylcarnitine, amino acid, and organic acid metabolites were measured via mass-spectroscopy. Plasma lipoproteins were measured via nuclear magnetic resonance spectroscopy. Spearman correlations were used to assess relationships for microRNA with inflammation and cardiometabolic measures. RA and control associations were compared using Fisher transformations. Results: Among RA subjects, plasma miR-143 was associated with plasma IL-6 and IL-8. No other RA microRNA was positively associated with disease activity or inflammatory markers. In RA, microRNA expression was associated with adiposity, both visceral adiposity (miR-146a, miR-21, miR-23b, and miR-27a) and thigh intra-muscular adiposity (miR-146a and miR-223). RA miR-146a was associated with greater concentrations of cardiometabolic risk markers (plasma short-chain dicarboxyl/hydroxyl acylcarnitines, triglycerides, large VLDL particles, and small HDL particles) and lower concentrations of muscle energy substrates (long-chain acylcarnitines and pyruvate). Despite RA and controls having similar microRNA levels, RA and controls differed in magnitude and direction for several associations with cytokines and plasma and skeletal muscle metabolic intermediates. Conclusion: Most microRNAs thought to be associated with RA disease activity and inflammation were more reflective of RA adiposity and impaired metabolism. These associations show that microRNAs in RA may serve as an epigenetic link between RA inflammation and cardiometabolic comorbidities." @default.
• W2952337170 created "2019-06-27" @default.
• W2952337170 creator A5005538765 @default.
• W2952337170 creator A5007221823 @default.
• W2952337170 creator A5017226394 @default.
• W2952337170 creator A5055488258 @default.
• W2952337170 creator A5060677592 @default.
• W2952337170 creator A5061496543 @default.
• W2952337170 creator A5071631262 @default.
• W2952337170 creator A5077512801 @default.
• W2952337170 date "2019-06-27" @default.
• W2952337170 modified "2023-10-15" @default.
• W2952337170 title "Plasma MicroRNAs in Established Rheumatoid Arthritis Relate to Adiposity and Altered Plasma and Skeletal Muscle Cytokine and Metabolic Profiles" @default.
• W2952337170 cites W1224580755 @default.
• W2952337170 cites W1907540161 @default.
• W2952337170 cites W1943492589 @default.
• W2952337170 cites W1978337436 @default.
• W2952337170 cites W1984875752 @default.
• W2952337170 cites W1990061381 @default.
• W2952337170 cites W2003877633 @default.
• W2952337170 cites W2010502044 @default.
• W2952337170 cites W2013907042 @default.
• W2952337170 cites W2014671368 @default.
• W2952337170 cites W2016112105 @default.
• W2952337170 cites W2043300911 @default.
• W2952337170 cites W2056603566 @default.
• W2952337170 cites W2057093679 @default.
• W2952337170 cites W2057217096 @default.
• W2952337170 cites W2058368576 @default.
• W2952337170 cites W2077582952 @default.
• W2952337170 cites W2091024743 @default.
• W2952337170 cites W2099783126 @default.
• W2952337170 cites W2103999934 @default.
• W2952337170 cites W2110177517 @default.
• W2952337170 cites W2122367003 @default.
• W2952337170 cites W2122839820 @default.
• W2952337170 cites W2124354788 @default.
• W2952337170 cites W2132608916 @default.
• W2952337170 cites W2147735172 @default.
• W2952337170 cites W2152348310 @default.
• W2952337170 cites W2157503340 @default.
• W2952337170 cites W2170688212 @default.
• W2952337170 cites W2172688163 @default.
• W2952337170 cites W2293424103 @default.
• W2952337170 cites W2431360341 @default.
• W2952337170 cites W2463612608 @default.
• W2952337170 cites W2464163698 @default.
• W2952337170 cites W2511892904 @default.
• W2952337170 cites W2581709974 @default.
• W2952337170 cites W2587011273 @default.
• W2952337170 cites W2625489186 @default.
• W2952337170 cites W2740510053 @default.
• W2952337170 cites W2744208468 @default.
• W2952337170 cites W2773310312 @default.
• W2952337170 cites W2790783431 @default.
• W2952337170 cites W2809768794 @default.
• W2952337170 cites W2810698763 @default.
• W2952337170 cites W2810826332 @default.
• W2952337170 cites W2889768360 @default.
• W2952337170 cites W2895841321 @default.
• W2952337170 cites W2906490346 @default.
• W2952337170 cites W750760073 @default.
• W2952337170 doi "https://doi.org/10.3389/fimmu.2019.01475" @default.
• W2952337170 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6610455" @default.
• W2952337170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31316517" @default.
• W2952337170 hasPublicationYear "2019" @default.
• W2952337170 type Work @default.
• W2952337170 sameAs 2952337170 @default.
• W2952337170 citedByCount "12" @default.
• W2952337170 countsByYear W29523371702020 @default.
• W2952337170 countsByYear W29523371702021 @default.
• W2952337170 countsByYear W29523371702022 @default.
• W2952337170 countsByYear W29523371702023 @default.
• W2952337170 crossrefType "journal-article" @default.
• W2952337170 hasAuthorship W2952337170A5005538765 @default.
• W2952337170 hasAuthorship W2952337170A5007221823 @default.
• W2952337170 hasAuthorship W2952337170A5017226394 @default.
• W2952337170 hasAuthorship W2952337170A5055488258 @default.
• W2952337170 hasAuthorship W2952337170A5060677592 @default.
• W2952337170 hasAuthorship W2952337170A5061496543 @default.
• W2952337170 hasAuthorship W2952337170A5071631262 @default.
• W2952337170 hasAuthorship W2952337170A5077512801 @default.
• W2952337170 hasBestOaLocation W29523371701 @default.
• W2952337170 hasConcept C104317684 @default.
• W2952337170 hasConcept C126322002 @default.
• W2952337170 hasConcept C134018914 @default.
• W2952337170 hasConcept C145059251 @default.
• W2952337170 hasConcept C171089720 @default.
• W2952337170 hasConcept C2776914184 @default.
• W2952337170 hasConcept C2777575956 @default.
• W2952337170 hasConcept C2779959927 @default.
• W2952337170 hasConcept C2780942790 @default.
• W2952337170 hasConcept C55493867 @default.
• W2952337170 hasConcept C71924100 @default.
• W2952337170 hasConcept C86803240 @default.
• W2952337170 hasConceptScore W2952337170C104317684 @default.
• W2952337170 hasConceptScore W2952337170C126322002 @default.
• W2952337170 hasConceptScore W2952337170C134018914 @default.
• W2952337170 hasConceptScore W2952337170C145059251 @default.
• W2952337170 hasConceptScore W2952337170C171089720 @default.

• next